Randomized Controlled Trial To Evaluate Efficacy And Safety Of The Polyvalent Anti-scorpion Venom Serum Of Birmex Versus Other Commercial Venom Serum In Children Population.
Phase of Trial: Phase III
Latest Information Update: 06 Feb 2013
At a glance
- Drugs Scorpion venom antitoxin (Primary)
- Indications Scorpion venom poisoning
- Focus Registrational; Therapeutic Use
- 01 May 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Aug 2011 Actual initiation date (Aug 2011) added as reported by ClinicalTrials.gov.
- 18 Aug 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.